A Phase II Study of Bryostatin 1 and Vincristine in Patients With Low or Intermediate Grade Non-Hodgkin's Lymphoma Progressing or Relapsing After a Prior Autologous Bone Marrow or Stem Cell Transplant
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bryostatin-1 (Primary) ; Vincristine (Primary)
- Indications Follicular lymphoma; Mantle-cell lymphoma; Marginal zone B-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Biomarker; Therapeutic Use
- 10 Jan 2013 Biomarkers information updated
- 09 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2010 Actual patient number (14) added as reported by ClinicalTrials.gov.